[ 1 ] Kasa P, Papp H, Kasa P Jr, et al. Donepezil dose-dependently inhibits acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain[J]. Neuroscience, 2000, 101(1): 89-100.
[ 5 ] Yasui-Furukori N, Furuya R, Takahata T, et al. Determination of donepezil, an acetylcholinesterase inhibitor, in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2002, 786(2): 261-265.
[6]
[ 6 ] Koeber R, Kluenemann HH, Waimer R, et al. Implementation of a cost-effective HPLC/UV-approach for medical routine quantification of donepezil in human serum[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2012, 881-882: 1-11.
[7]
[ 7 ] Apostolou C, Dotsikas Y, Kousoulos C, et al. Quantitative determination of donepezil in human plasma by liquid chromatography/tandem mass spectrometry employing an automated liquid？liquid extraction based on 96-well format plates: Application to a bioequivalence study[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2007, 848(2): 239-244.
